z-logo
Premium
Endostatin inhibits nitric oxide and diminishes VEGF and collagen XVIII in squamous carcinoma cells
Author(s) -
Hebert Carla,
Siavash Hessam,
Norris Kathleen,
Nikitakis Nikolaos G.,
Sauk John J.
Publication year - 2004
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.20692
Subject(s) - endostatin , nitric oxide , vegf receptors , cancer research , squamous carcinoma , carcinoma , chemistry , medicine , pathology , endocrinology
Low pO 2 values are a common finding among oral squamous cell carcinomas (SCC). Our objective was to determine the role that oxygen tension plays on the direct tumor effect of endostatin (ES). Squamous carcinoma cell lines were grown under normoxic or hypoxic conditions and treated with endostatin (ES), nitric oxide (NO) donors, NO scavengers, NO synthase inhibitors, or transduced with AdenoVec™‐hEndo or AdenoVec™Null vectors. The expression of vascular endothelial growth factor (VEGF) and collagen XVIII were determined by RT‐PCR and protein levels assessed by Western blot analyses. Our studies demonstrated that collagen XVIII and VEGF are expressed and responsive to ES in a limited number of SCC cell lines during normoxia but were most responsive when grown under hypoxic conditions. VEGF and collagen XVIII were downregulated by both ES and transduction of cells with AdenoVec™‐hEndo. The effects of ES on SCC cells were enhanced by aminoguanidine (Ag), L ‐NAME, and diphenyleneiodonium chloride (DPI). Endostatin and transduced with ES vectors diminished the levels of NO whereas NO donors enhanced VEGF expression and collagen XVIII expression. In conclusion, the direct effect of endostatins on tumor cells is most effective under conditions of low oxygen tension and can be potentiated by the use of nitric oxide synthase inhibitors or NO scavengers. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here